down arrow

Trans Genic Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3635720000
  • TKS: 2342
JPY
256.00
0.00 (0.00%)

Sep 18

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Trans Genic Inc.
Cyfuse Biomedical KK
Oncolys BioPharma, Inc.
OncoTherapy Science, Inc.
Carna Biosciences, Inc.
MEDINET Co., Ltd.
Chiome Bioscience, Inc.
Kidswell Bio Corp.
StemCell Institute
SUSMED, Inc.
Stella Pharma Corp.

Why is Trans Genic Inc. ?

1
Weak Long Term Fundamental Strength with a -155.25% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate -155.25% of over the last 5 years
3
With a growth in Operating Profit of 182.11%, the company declared Very Positive results in Jun 26
  • The company has declared positive results for the last 2 consecutive quarters
  • ROCE(HY) Highest at 0.66%
  • INTEREST COVERAGE RATIO(Q) Highest at 1,274.74
  • NET PROFIT(Q) At JPY 136.19 MM has Grown at 143.08%
4
With ROE of -6.29%, it has a risky valuation with a 0.74 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 19.07%, its profits have fallen by -63.7%
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 19.07% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 43.52%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Trans Genic Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Trans Genic Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Trans Genic Inc.
19.07%
0.11
87.56%
Japan Nikkei 225
43.52%
1.48
29.43%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.20%
EBIT Growth (5y)
-155.25%
EBIT to Interest (avg)
15.64
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.65
Tax Ratio
53.02%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.75%
ROE (avg)
10.01%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.74
EV to EBIT
-148.28
EV to EBITDA
31.13
EV to Capital Employed
0.77
EV to Sales
0.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.52%
ROE (Latest)
-6.29%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
ROCE(HY)

Highest at 0.66%

INTEREST COVERAGE RATIO(Q)

Highest at 1,274.74

NET PROFIT(Q)

At JPY 136.19 MM has Grown at 143.08%

RAW MATERIAL COST(Y)

Fallen by -2.55% (YoY

NET SALES(Q)

Highest at JPY 3,659.07 MM

OPERATING PROFIT(Q)

Highest at JPY 199.78 MM

OPERATING PROFIT MARGIN(Q)

Highest at 5.46 %

PRE-TAX PROFIT(Q)

Highest at JPY 156.85 MM

EPS(Q)

Highest at JPY 8.17

-10What is not working for the Company
CASH AND EQV(HY)

Lowest at JPY 4,394.01 MM

INTEREST(Q)

Highest at JPY 15.67 MM

Here's what is working for Trans Genic Inc.

Interest Coverage Ratio
Highest at 1,274.74
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Pre-Tax Profit
At JPY 156.85 MM has Grown at 150%
over average net sales of the previous four periods of JPY 62.74 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Net Profit
At JPY 136.19 MM has Grown at 143.08%
over average net sales of the previous four periods of JPY 56.03 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (JPY MM)

Net Sales
Highest at JPY 3,659.07 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Operating Profit
Highest at JPY 199.78 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Operating Profit Margin
Highest at 5.46 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at JPY 156.85 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

EPS
Highest at JPY 8.17
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Raw Material Cost
Fallen by -2.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Trans Genic Inc.

Interest
At JPY 15.67 MM has Grown at 66.4%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Interest
Highest at JPY 15.67 MM
in the last five periods and Increased by 66.4% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv
Lowest at JPY 4,394.01 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Footer loading